Mayo Clinic researchers validated an AI model that can detect pancreatic cancer up to three years before diagnosis using routine abdominal CT scans. The approach, described as identifying subtle biomarkers and minute tissue-architecture shifts that radiologists may miss, is presented as a breakthrough in early detection using existing imaging. If sustained across additional cohorts, the model could shift clinical practice by enabling earlier triage and follow-up for patients with imaging that currently falls below actionable thresholds. It also adds to the growing emphasis on extracting high-dimensional signal from standard-of-care scans rather than relying solely on novel biomarkers. The key near-term variable will be prospective validation and how the system performs across diverse sites, scanners, and patient risk profiles.